HPNE introduces defined tubing routing for single-use facilities
Flexible support system simplifies and secures tubing paths for biopharmaceutical manufacturers.
High Purity New England (HPNE), a supplier of biopharma equipment and process systems has launched its new line of defined tubing routing (DTR), a flexible tubing support system targeted for single-use biopharmaceutical manufacturing.
This modular system holds silicon tubing securely, eliminating dips and preventing dips that occur in unsupported pressurized lines.
For the first time, skid builders, process engineers, and facilities managers have a proven, mass-produced, and versatile option specifically engineered to define supported and clean routing of single-use tubing.
DTR simplifies single-use tubing management in a cleanroom environment, with colour-coded rigid supports for easy visual identification of each tube connection.
With solid and supported bridges, even over short spans, it securely holds any length of single-use tubing.
The combination of clips and routes are mounted to brackets to provide rigid and secure support, even over long tube runs.
Portable mounting panels can be engineered to get tubing off the floor without damaging cleanroom walls.
Megan Baillie, Product Specialist at HPNE, described DTR as a “simple solution to a ubiquitous problem". She added: “Skid builders will love the versatility of this product as it can be modified for different needs, including attaching to walls, chromatography columns, and exfiltration systems.”
DTR comes in 2.9-m length, fits a wide range of clips and standard tubing sizes (6 mm–19 mm) and comes in many colours.
As the US facility installer, HPNE can customize DTR for a variety of applications, including for new builds and retrofitted into existing single-use facilities; improved aesthetic to ensure a process appears organized and secure for virtual inspections; and reduced human error and trip hazards.
Related News
-
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News The 2024 Pharma Outsourcing Forecast: strategic partnerships across global landscapes
For the pharmaceutical industry, outsourcing drug development, manufacturing, and research operations to contract organisations is not just a passing trend – increasingly, the partnership between drug sponsor and drug vendor is one of vital impor... -
News Gerresheimer predicts weight-loss drug deals to account for 4% of yearly growth
Dietmar Siemssen, CEO of German primary packaging manufacturer Gerresheimer, states that approximately 4% of the company’s revenue growth each year to come from deals with drugmakers of weight loss and diabetes products, particularly GLP-1 class ... -
News Novel approach to creating sustainable packaging from rice husks
Researchers have created a new approach to the designing of eco-friendly nanofibres extracted from rice husks, addressing the critical need for sustainable packaging materials in food and biopharmaceutical products. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Coronary drug-coated medical device receives US FDA approval
Boston Scientific announced the FDA approval of their medical device AGENT Drug-Coated Balloon (DCB) for the indication of coronary in-stent restenosis in coronary artery disease patients. -
News CPHI Online Webinar Series – Innovative Strategies for B2B Pharma Marketeers
On February 20, 2024, CPHI Online hosted a webinar on Innovative Strategies for B2B Pharma Marketeers. Featuring expert speakers from across the pharmaceutical value chain, this webinar delves into how B2B pharma marketeers can create better content to... -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance